Search Within

Robert Motzer

Formats
  1. Journal Article (609)
  2. Meeting Abstract (574)
  3. Book Section (20)
  4. Review (13)
  5. Conference Paper (6)
  6. Correspondence (6)
  7. Guidelines (5)
  8. Research Letter (5)
  9. Editorial (3)
  10. Book Whole (2)
Groups
  1. Department of Medicine (1243)
  2. Genitourinary Oncology Service (1243)
  3. Solid Tumor Oncology Division (1243)
  4. Surgery (288)
  5. Urology (279)
  6. Survivorship Research (252)

More Groups

People
  1. George Bosl (182)
  2. Martin Voss (176)
  3. Darren Feldman (157)
  4. Dean Bajorin (128)
  5. Paul Russo (119)
  6. Joel Sheinfeld (110)

More People

Years
  1. 2025 (26)
  2. 2024 (49)
  3. 2023 (47)
  4. 2022 (64)
  5. 2021 (65)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (444)
  2. Annals of Oncology (81)
  3. BJU International (40)
  4. Cancer (35)
  5. European Journal of Cancer (34)
  6. Clinical Cancer Research (33)

More Publications

Publishers
  1. American Society of Clinical Oncology (447)
  2. Elsevier Science, Inc. (111)
  3. Oxford University Press (111)
  4. Elsevier Inc. (89)
  5. Wiley Blackwell (86)
  6. American Association for Cancer Research (58)

More Publishers

Results (1243)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of ifosfamide plus cisplatin‐based chemotherapy as salvage therapy for patients with refractory germ cell tumors
    Journal Article

    Motzer, R. J.; Cooper, K.; Geller, N. L.; Bajorin, D. F.; Dmitrovsky, E.; Herr, H.; Morse, M.; Fair, W.; Sogani, P.; Russo, P.; more...
    Cancer (1990)

    Fulltext@MSK | Save
  • Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency
    Journal Article

    Motzer, R. J.; Niedzwiecki, D.; Isaacs, M.; Menendez-Botet, C.; Tong, W. P.; Flombaum, C.; Scher, H. I.; Bosl, G. J.
    Cancer Chemotherapy and Pharmacology (1990)

    Fulltext@MSK | Save
  • The effect of a 7‐day delay in chemotherapy cycles on complete response and event‐free survival in good‐risk disseminated germ cell tumor patients
    Journal Article

    Motzer, R. J.; Geller, N. L.; Bosl, G. J.
    Cancer (1990)

    Fulltext@MSK | Save
  • Carboplatin, etoposide, and bleomycin for patients with poor‐risk germ cell tumors
    Journal Article

    Motzer, R. J.; Cooper, K.; Geller, N. L.; Pfister, D. G.; Lin, S. Y.; Bajorin, D.; Scher, H. I.; Herr, H.; Fair, W.; Morse, M.; more...
    Cancer (1990)

    Fulltext@MSK | Save
  • Blood group antigens (BGA) in human germ cell tumors
    Meeting Abstract

    Reuter, V. E.; Cordon-Cardo, C.; Motzer, R.; Bosl, G. J.
    Modern Pathology (1988)

    Fulltext@MSK | Save
  • Blood group antigens (BGA) in human germ-cell tumors
    Meeting Abstract

    Reuter, V. E.; Cordon-Cardo, C.; Motzer, R.; Bosl, G. J.
    Laboratory Investigation (1988)

    Fulltext@MSK | Save
  • Blood group-related antigens in human germ cell tumors
    Journal Article

    Motzer, R. J.; Reuter, V. E.; Cordon-Cardo, C.; Bosl, G. J.
    Cancer Research (1988)

    Fulltext@MSK | Save
  • Advanced seminoma: The role of chemotherapy and adjunctive surgery
    Journal Article

    Motzer, R. J.; Bosl, G. J.; Geller, N. L.; Penenberg, D.; Yagoda, A.; Golbey, R.; Whitmore, W. F. Jr; Fair, W. R.; Sogani, P.; Herr, H.; more...
    Annals of Internal Medicine (1988)

    Fulltext@MSK | Save
  • Treatment of poor risk nonseminomatous germ cell tumor (NSGCT) patients (pts) with carboplatin (CBDCA) + etoposide (E) + bleomycin (B)
    Meeting Abstract

    Motzer, R. J.; Bosl, G. J.; Yagoda, A.; Golbey, R.
    Proceedings of the American Association for Cancer Research Annual Meeting (1987)

    Fulltext@MSK | Save
  • Chemotherapy for germ cell tumors
    Journal Article

    Motzer, R. J.; Bosl, G. J.
    Urologic Clinics of North America (1987)

    Fulltext@MSK | Save